Valeo Financial Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-300
Closed -$37 679
2023
Q4
$37 Buy
+300
New +$30.6K ﹤0.01% 655

Other funds holding DXCM

Valeo Financial Advisors's DXCM Position: Q2 2026 in Review

Valeo Financial Advisors reduced its DexCom (DXCM) stake by 22% in Q2 2026, selling an estimated $97.4K and leaving 5,206 shares worth $351K. The position accounts for 0.01% of the portfolio, ranked #563.

Valeo Financial Advisors first reported a position in DXCM in Q4 2017 and has held it in 26 quarters since. The position peaked at $912K in Q2 2025. 463 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Valeo Financial Advisors held 5,206 shares of DexCom worth $351K as of Q2 2026.
  • Valeo Financial Advisors sold 1,462 DexCom shares in Q2 2026, an estimated $97.4K.
  • DexCom made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #563 holding.
  • Valeo Financial Advisors first reported a position in DexCom in Q4 2017 and has held it in 26 quarters since.
  • Valeo Financial Advisors's DexCom position peaked at $912K in Q2 2025.
  • 463 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.